It is intended to provide a diagnostic for schizophrenia. Namely, a diagnostic for schizophrenia containing as the active ingredient an antibody against basic fibroblast growth factor. Schizophrenia is diagnosed by assaying the basic fibroblast growth factor in the serum with the use of the above antibody.
申请公布号
WO03060518(A1)
申请公布日期
2003.07.24
申请号
WO2003JP00292
申请日期
2003.01.15
申请人
JAPAN SCIENCE AND TECHNOLOGY CORPORATION;HASHIMOTO, KENJI;ITO, MASAOMI;SHIMIZU, EIJI
